Matching slides 78,138
Current window 64,981-65,010
Pages 2,605
Rows per page 30
Component: Chartclear collectionreset all

Component

64,981-65,010 of 78,138

filter-aware
20
The slide uses a Gantt chart to illustrate the overlapping timelines of two batches of development.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · Roadmap1 hit
24
The slide uses a process diagram to explain the technical methodology of Absci's drug discovery platform.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · Traction1 hit
26
SPR stands for Surface Plasmon Resonance, a standard technique for measuring binding affinity.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · Traction1 hit
29
The slide uses a histogram to visualize the distribution of binding affinity (-log10(Kd)) for designed variants versus the wild-type baseline.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · Solution1 hit
33
Includes a Kaplan-Meier survival curve as evidence for the clinical relevance of TLS.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations 1 hit
37
Uses a comparative timeline to illustrate process efficiency gains.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · Timeline1 hit
39
The chart uses a grouped bar chart to illustrate the economic structure across five categories: Research Funding/Cost, Upfront Payment, Clinical Milestones, Commercial Milestones, and Royalties.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations 1 hit
05
The slide uses a process flow diagram to contrast time-to-diagnosis and a bar chart to illustrate the exponential mortality risk of delayed treatment.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
09
The slide highlights the superior NPV of IL-6 compared to standard biomarkers using a table and an ROC curve.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
10
The slide uses a horizontal bar chart to represent progress through Research, Development, Clinical Testing, and Regulatory stages.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
12
Includes a specific capital requirement estimate at the bottom.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
06
Includes a callout highlighting J&J's Darzalex Faspro achieving 85% conversion in under 2 years.Comera | Investor Presentation Deck | 16 slides · Comera
Pitch deck Investor relations Beat · Evidence & ProofLoop · Golden Circle1 hit
05
The chart uses a stacked area visualization to show cumulative growth across different industry verticals.D-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · InterestLoop · Logic Chain1 hit
08
The slide uses a dual-track timeline to contrast D-Wave's specific product history with the general industry's gate-model development.D-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · InterestLoop · Logic Chain1 hit
19
The slide uses a growth curve visualization to link product releases to market expansion.D-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
23
The slide uses a scientific publication as social proof and a log-log chart to demonstrate performance scaling.D-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · Action1 hit
13
Uses a combination of SEM imagery for material changes and diagrams for structural/systemic improvements.Eos Energy | Investor Presentation Deck | 24 slides · Eos Energy Enterprises
Pitch deck Investor relations Beat · Solution & ApproachLoop · Quick Win Big Bet1 hit
20
The chart uses a waterfall structure to show how specific initiatives (R&D, Engineering, Supply Chain, Operations) reduce the cost components (Materials, Labor, Overhead) over time.Eos Energy | Investor Presentation Deck | 24 slides · Eos Energy Enterprises
Pitch deck Investor relations Beat · Action1 hit
13
The slide uses a structural biology approach to explain the mechanism of action for their therapeutic platform.Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
14
The slide uses a biological process diagram to illustrate how the inhibitor prevents the dimerization of private receptors with the shared receptor.Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
28
The slide uses stacked bar charts to illustrate the composition of capital (CET1, AT1, HoldCo) and compares them against specific regulatory guidance levels.UBS | Results Presentation Deck | 31 slides · UBS
Conference presentation Investor relations Beat · Action1 hit
12
Uses concentric circles to represent market segments.Vivid Seats | Investor Presentation Deck | 24 slides · Vivid Seats
Pitch deck Investor relations Beat · Market SizeLoop · Golden Circle1 hit
18
The chart highlights a positive trend in customer retention/repeat purchase behavior.Vivid Seats | Investor Presentation Deck | 24 slides · Vivid Seats
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
19
The slide details a dual-class share structure with 196M total shares outstanding.Vivid Seats | Results Presentation Deck | 22 slides · Vivid Seats
Conference presentation Investor relations 1 hit
21
2020 data omitted due to pandemic distortion.Vivid Seats | Results Presentation Deck | 22 slides · Vivid Seats
Conference presentation Investor relations 1 hit
05
Data sourced from China National Bureau of Statistics (CNBS).Yatsen | Results Presentation Deck | 15 slides · Yatsen
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
07
The slide highlights a shift in revenue mix towards skincare brands despite a slight YoY decline in absolute revenue.Yatsen | Results Presentation Deck | 15 slides · Yatsen
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
09
The chart highlights a significant reduction in store count, specifically noting that adjustments were mostly completed in 2022.Yatsen | Results Presentation Deck | 15 slides · Yatsen
Conference presentation Investor relations Beat · Satisfaction1 hit
12
The chart shows a 3.8 percentage point YoY increase in total operating expenses.Yatsen | Results Presentation Deck | 15 slides · Yatsen
Conference presentation Investor relations Beat · Action1 hit
14
The chart displays two distinct metrics: a running balance of cash/investments (top row of ovals) and quarterly operating cashflow (bars).Yatsen | Results Presentation Deck | 15 slides · Yatsen
Conference presentation Investor relations Beat · Action1 hit